title: Central myelin gene expression during postnatal development in rats exposed to nicotine gestationally.
abstract: Abnormal myelin gene expression in the central nervous system (CNS) is associated with many mental illnesses, including psychiatric disorders and drug addiction. We have previously shown that prenatal exposure to nicotine, the major psychoactive component in cigarette smoke, alters myelin gene expression in the CNS of adolescent rats. To examine whether this effect is specific for adolescents, we examined myelin gene expression in the CNS of juveniles and adults. Pregnant Sprague-Dawley rats were treated with nicotine (3 mg/kg/day; GN) or saline (GS) via osmotic mini pumps from gestational days 4-18. Both male and female offspring were sacrificed at postnatal day P20-21 (juveniles), P35-36 (adolescents), or P59-60 (adults). Three limbic brain regions, the prefrontal cortex (PFC), caudate putamen (CPu), and nucleus accumbens (NAc), were dissected. The expression of genes encoding major myelin components was evaluated using quantitative RT-PCR. We found that GN altered myelin gene expression in juveniles with brain region and sex differences. The pattern of alteration was different from that observed in adolescents. Although these genes were expressed normally in male adults, we observed decreased expression in GN-treated female adults, especially in the CPu. Thus, GN altered myelin gene expression throughout postnatal development and adulthood. The effect on adolescents was quite different from that at other ages, which correlated with the unique symptoms of many psychiatric disorders during adolescence.
authors: Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22911, United States.
authors: Junran
authors: J
authors: Cao
authors: Jennifer B
authors: JB
authors: Dwyer
authors: Nicole M
authors: NM
authors: Gautier
authors: Frances M
authors: FM
authors: Leslie
authors: Ming D
authors: MD
authors: Li
mesh_terms: D000367:Age Factors; D000818:Animals; D001921:Brain / Q000254:growth & development / Q000378:metabolism*; D005260:Female; D015870:Gene Expression; D008297:Male; D018811:Maternal Exposure; D009186:Myelin Sheath / Q000235:genetics / Q000378:metabolism*; D009538:Nicotine / Q000009:adverse effects*; D009714:Nucleus Accumbens / Q000254:growth & development / Q000378:metabolism; D017397:Prefrontal Cortex / Q000254:growth & development / Q000378:metabolism; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000378:metabolism*; D011699:Putamen / Q000254:growth & development / Q000378:metabolism; D017207:Rats, Sprague-Dawley
chemical_list: D009538:Nicotine
keywords: Development; Gestational; Myelin; Nicotine; Sex; Smoking
references: J Clin Psychiatry. 1996;57 Suppl 9:24-34
references: 8823347
references: Int J Neuropsychopharmacol. 2007 Aug;10(4):547-55
references: 17291372
references: Science. 1998 Jun 5;280(5369):1610-3
references: 9616125
references: Annu Rev Neurosci. 2008;31:535-61
references: 18558866
references: Brain Res. 2012 Dec 3;1487:61-8
references: 22789906
references: Brain Res Mol Brain Res. 2004 Dec 20;132(2):168-80
references: 15582156
references: Psychopharmacology (Berl). 2007 Aug;193(2):199-213
references: 17404712
references: Proc Natl Acad Sci U S A. 2012 Oct 16;109 Suppl 2:17186-93
references: 23045653
references: Psychopharmacology (Berl). 2007 Nov;195(1):117-24
references: 17653695
references: Dev Neuropsychol. 2009;34(1):1-36
references: 19142764
references: Neuroreport. 1992 Apr;3(4):315-8
references: 1515589
references: J Neurosci Res. 2002 Jun 15;68(6):647-54
references: 12111826
references: Anal Biochem. 1999 May 15;270(1):41-9
references: 10328763
references: Neuroreport. 1994 Jul 21;5(12):1449-52
references: 7948836
references: Physiol Rev. 2001 Apr;81(2):871-927
references: 11274346
references: Nat Neurosci. 1999 Oct;2(10):859-61
references: 10491602
references: Trends Neurosci. 2008 Jul;31(7):361-70
references: 18538868
references: Neurotoxicol Teratol. 1987 Mar-Apr;9(2):95-8
references: 3657758
references: Nat Genet. 2003 Mar;33(3):366-74
references: 12590258
references: Brain Res. 2006 Jun 13;1094(1):119-26
references: 16690037
references: Proc Natl Acad Sci U S A. 2007 May 8;104(19):8131-6
references: 17483467
references: Arch Gen Psychiatry. 1994 Jun;51(6):477-84
references: 8192550
references: Neurochem Res. 2008 Oct;33(10):1940-9
references: 18404371
references: J Neurosci. 1995 Jun;15(6):4488-95
references: 7540676
references: J Neurosci. 2003 Jun 15;23(12):4967-74
references: 12832519
references: Neurotoxicol Teratol. 2001 Sep-Oct;23(5):431-6
references: 11711245
references: Transl Psychiatry. 2013 Apr 16;3:e247
references: 23591971
references: Neurobiol Aging. 2004 Jan;25(1):5-18; author reply 49-62
references: 14675724
references: Nat Rev Neurosci. 2008 Dec;9(12):947-57
references: 19002191
references: Int J Neuropsychopharmacol. 2011 Mar;14(2):157-74
references: 20196919
references: Eur J Neurosci. 2008 Jun;27(11):2952-61
references: 18588535
references: Dev Neurosci. 2006;28(6):479-87
references: 17028425
references: Alcohol Clin Exp Res. 2004 Dec;28(12):1779-88
references: 15608593
references: Cell Mol Life Sci. 2012 Sep;69(17):2879-94
references: 22441408
references: Addict Biol. 2012 Jan;17(1):141-8
references: 21070508
references: Ther Adv Neurol Disord. 2012 May;5(3):147-59
references: 22590479
references: J Neurol Sci. 2009 Nov 15;286(1-2):76-80
references: 19625027
references: Nat Rev Neurosci. 2004 Sep;5(9):701-8
references: 15322528
references: Int J Neuropsychopharmacol. 2011 Feb;14(1):91-106
references: 20426880
references: J Neurochem. 2008 Oct;107(1):1-19
references: 18643793
references: Neurotoxicol Teratol. 2012 Nov-Dec;34(6):560-70
references: 23022448
references: Am J Psychiatry. 2000 May;157(5):816-8
references: 10784477
references: J Cell Biol. 2004 Aug 30;166(5):731-42
references: 15337780
references: Neurochem Res. 2009 Jan;34(1):138-48
references: 18478328
references: Brain Pathol. 1995 Jul;5(3):275-81
references: 8520727